These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6409240)

  • 1. Adverse reactions during treatment with amiodarone hydrochloride.
    McGovern B; Garan H; Kelly E; Ruskin JN
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):175-80. PubMed ID: 6409240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
    Sobol SM; Rakita L
    Circulation; 1982 Apr; 65(4):819-24. PubMed ID: 7060263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
    Kumana CR; Tanser P; Eydt J
    Hum Toxicol; 1985 Mar; 4(2):169-76. PubMed ID: 4007880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
    Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
    Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
    Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug.
    Parra O; Ruiz J; Ojanguren I; Navas JJ; Morera J
    Eur Respir J; 1989 Oct; 2(9):905-7. PubMed ID: 2806517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced polymorphous ventricular tachycardia.
    Sclarovsky S; Lewin RF; Kracoff O; Strasberg B; Arditti A; Agmon J
    Am Heart J; 1983 Jan; 105(1):6-12. PubMed ID: 6849241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.